Meta-analysis Evaluating the Use of Statins to attenuate Cardiotoxicity in Cancer Patients receiving Anthracyclines and Trastuzumab-based Chemotherapy

Statin Exposure and Risk of Heart Failure After Anthracycline‐ or Trastuzumab‐Based Chemotherapy for Early Breast Cancer: A Propensity Score‒Matched Cohort Study

(2021) Husam Abdel‐Qadir et al.   Journal of the American Heart Association

Effect of Rosuvastatin in Preventing Chemotherapy-Induced Cardiotoxicity in Women With Breast Cancer: A Randomized, Single-Blind, Placebo-Controlled Trial

(2019) Maryam Nabati et al.   JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS

Cardio-protective effect of statins in patients with HER2 positive breast cancer receiving trastuzumab therapy

(2018) Oscar Calvillo-Argüelles et al.   CANADIAN JOURNAL OF CARDIOLOGY

Chronic Statin Administration May Attenuate Early Anthracycline-Associated Declines in Left Ventricular Ejection Function

(2015) Runyawan Chotenimitkhun et al.   CANADIAN JOURNAL OF CARDIOLOGY

HMG-CoA-reductase inhibitor co-therapy lowers the risk for incident heart failure in farmorubicin recipients for two cancer locations

(2014) A. G. Tase et al.   EUROPEAN HEART JOURNAL

Effect of Statin Therapy on the Risk for Incident Heart Failure in Patients With Breast Cancer Receiving Anthracycline Chemotherapy

(2012) Sinziana Seicean et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Efficiency of Atorvastatin in the Protection of Anthracycline-Induced Cardiomyopathy

(2011) Zeydin Acar et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY